[PDF][PDF] Navigating the cellular pathways: Chaperone-mediated autophagy as a targeted approach for management of parkinson's disease

PS Kawade, SU Nagrik, GJ Lamkhade… - … of Pharmaceutical and …, 2023 - academia.edu
Parkinson's disease (PD) is a common neurodegenerative condition marked by the
degeneration of dopaminergic neurons and the amassing of α-synuclein protein in Lewy …

Chaperone-mediated autophagy as a therapeutic target for Parkinson disease

P Campbell, H Morris, A Schapira - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: Parkinson disease (PD) is the most common neurodegenerative movement
disorder. Currently only symptomatic treatments exist for PD, and so the search for potential …

Chaperone mediated autophagy to the rescue: a new-fangled target for the treatment of neurodegenerative diseases

M Xilouri, L Stefanis - Molecular and Cellular Neuroscience, 2015 - Elsevier
One of the main pathways of lysosomal proteolysis is chaperone-mediated autophagy
(CMA), which represents a selective mechanism for the degradation of specific soluble …

[HTML][HTML] Pathogenic aspects and therapeutic avenues of autophagy in Parkinson's disease

R Kinet, B Dehay - Cells, 2023 - mdpi.com
The progressive aging of the population and the fact that Parkinson's disease currently does
not have any curative treatment turn out to be essential issues in the following years, where …

[HTML][HTML] Therapeutic potential of autophagy-enhancing agents in Parkinson's disease

TE Moors, JJM Hoozemans, A Ingrassia… - Molecular …, 2017 - Springer
Converging evidence from genetic, pathological and experimental studies have increasingly
suggested an important role for autophagy impairment in Parkinson's Disease (PD). Genetic …

[HTML][HTML] Autophagy-lysosomal pathway as potential therapeutic target in Parkinson's disease

SR Bonam, C Tranchant, S Muller - Cells, 2021 - mdpi.com
Cellular quality control systems have gained much attention in recent decades. Among
these, autophagy is a natural self-preservation mechanism that continuously eliminates toxic …

[HTML][HTML] Targeting macroautophagy as a therapeutic opportunity to treat parkinson's disease

I Sanchez-Mirasierra, S Ghimire… - Frontiers in cell and …, 2022 - frontiersin.org
Macroautophagy, an evolutionary conserved catabolic process in the eukaryotic cell,
regulates cellular homeostasis and plays a decisive role in self-engulfing proteins, protein …

[HTML][HTML] Targeting chaperone-mediated autophagy for Parkinson's disease therapy

YT Wang, JH Lu - Neural Regeneration Research, 2023 - journals.lww.com
Parkinson's disease (PD) is the second most prevalent neurodegenerative disease.
Epidemiological projections for the global incidence of PD indicate that the number of …

Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy

Y Liu, L Tan, MS Tan - Molecular and Cellular Biochemistry, 2023 - Springer
Chaperone-mediated autophagy (CMA) is the selective degradation process of intracellular
components by lysosomes, which is required for the degradation of aggregate-prone …

Role of autophagy in Parkinson's disease

S Cerri, F Blandini - Current medicinal chemistry, 2019 - ingentaconnect.com
Autophagy is an essential catabolic mechanism that delivers misfolded proteins and
damaged organelles to the lysosome for degradation. Autophagy pathways include …